신오케미칼

비상장계속사업자

sinokemkikljujoo

허세행

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

신오케미칼

Business Reg. No. 1078195530 · CEO 허세행

I.Investment Overview

Target신오케미칼 (1078195530)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명신오케미칼
영문명sinokemkikljujoo
대표자허세행
사업자등록번호1078195530
법인등록번호1101112161779
설립일2001.02.02

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW490.92021479.42022423.92023415.32024397.92025
영업이익100M KRW8202112.520220.82023-2.920247.42025
순이익100M KRW8.320217.62022-52023-9.720240.72025
Item20252024202320222021
자산총계361.6억원359.9억원284.3억원241.9억원223.6억원
부채총계209.2억원208.2억원208.3억원160.9억원150.2억원
자본총계152.4억원151.7억원76억원81억원73.4억원
매출액397.9억원415.3억원423.9억원479.4억원490.9억원
영업이익7.4억원-2.9억원7,736만원12.5억원8억원
순이익6,928만원-9.7억원-5억원7.6억원8.3억원

VI.Financial Ratios

FY2025 basis

1.86%

영업이익률

0.17%

순이익률

0.19%

ROA

0.45%

ROE

137.3%

부채비율

42.14%

자기자본비율

VII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

신오케미칼 투심보고서 | Alpha Lenz